INTRODUCTION
One of the most common manifestations of advanced cancer is the development of metabolic symptoms called cancer cachexia. Cancer cachexia is often referred to cancer anorexia-cachexia syndrome (CACS) because it often shows symptoms of anorexia accompanied by symptoms of cachexia 1 in cancer patients. In 2011, an international consensus dened cancer cachexia as: "a multifactorial syndrome characterized by an ongoing loss of skeletal muscle with or without loss of fat mass that cannot be completely reversed by conventional nutritional support and leads to progressive 2 functional disorders. The main clinical features of cancer cachexia are unintentional weight loss accompanied by anorexia, systemic inammation, insulin resistance, and 2 increase resting energy expenditure (REE).
Previous studies have shown that half of all cancer patients lose weight and one third lose more than 5% of body weight. 3 Cachexia accounts for about 20% of deaths from cancer. Cancer cachexia negatively affects quality of life, response to 4, 5 chemotherapy, and life expectancy.
Adiponectin is a protein, which is most secreted by adipose tissue. Adiponectin plays a role in increasing insulin sensitivity, anti-inammation, anti-atherogenic, proapoptotic, and anti-proliferative. Adiponectin levels are inversely proportional to the risk of diabetes, coronary heart disease, and some malignancies. Many cancer cell lines express adiponectin receptors, and adiponectin in vitro limits cell proliferation and induces apoptosis. Recent in vitro studies show properties that limit the growth and antiangiogenic 6 growth of adiponectin.
Ophiocephalus striatus or snakehead sh is a potential source of albumin. Previous studies reported that snakehead sh extract was in fact able to maintain the albumin value of hospitalized patients and accelerate the healing process for 7, 8 patients. This study aims to determine the effects of Ophiocephalus striatus extract on serum adiponectin levels of cancer cachexia patients.
METHODS
This study was an open label clinical trial designed with one group pretest posttest. This study was conducted at Haji Adam Malik General Hospital Medan from January 2019 to June 2019 with the approval from the Research Ethics Commission of Faculty of Medicine of Universitas Sumatera Utara. The informed consent was obtained from subjects who were willing to participate in this study.
Patients who have met the criteria as the subjects were given the extract of Ophiocephalus striatus for 2 weeks. Inclusion criteria in this study were: patients who have been diagnosed with cancer, age ≥18 years, patients who were willing to be the 2 subject, patients who met the criteria of cachexia. The exclusion criteria in this study were: pregnancy, GFR 2 <15ml/min/1.73 m , proteinuria ≥+3, severe systemic disease: lung infection, sepsis, history of other chronic diseases: diabetes mellitus, coronary heart disease, stroke, thyroid dysfunction. The Ophiocephalus striatus extracts used in this study was manufacturer sachets containing 5000 mg Ophiocephalus striatus each sachet. The extract was registered by national food and drug agency. All subjects were given the extract twice a day for two weeks with th monitoring of medication compliance. On the 15 day, blood samples were collected by the laboratory assistant for complete blood count, liver and kidney function, and adiponectin serum levels.
RESULT
This study was attended by 30 cancer cachexia patients. The basic characteristic of the subjects was described in table 1. The mean age of the subjects was 52 ±17 years. The mean 2 body mass index (BMI) was 17.14±1.66 kg/m . Median adiponectin levels were 5.51 (1.30-22.2) ng/mL. The mean albumin level were 2.46 ± 0.46 gr/dL. 
Medicine
One of the most common manifestations of advanced cancer is the development of metabolic symptoms called cancer cachexia. Adiponectin plays a role in increasing insulin sensitivity, anti-inammation, antiatherogenic, proapoptotic, and anti-proliferative. Ophiocephalus striatus or snakehead sh is a potential source of albumin. This study aims to determine the effects of Ophiocephalus striatus extract on serum adiponectin levels of cancer cachexia patients. This study was an open label clinical trial with the design of one group pretest posttest. The study was conducted on January-June 2019 at Haji Adam Malik Hospital in Medan with the approval of the USU FK Research Ethics Commission. Data were analyzed using the SPPS program where p <0.05 was considered signicant. The results of this study showed there were signicant differences in the serum adiponectin levels of the subjects before and after administration of Ophiocephalus striatus extract for two weeks. The increase in serum albumin levels of cancer cachexia patients was obtained after administration of 5000mg Ophiocephalus striatusextract twice a day for two weeks. a normal distribution; mean±SD b abnormal distribution; median (minimum-maximum) Table 2 showed a comparison of clinical and laboratory parameters before and after therapy. The results showed that there were signicant differences in the serum albumin and adiponectin levels of the subjects before and after receiving the extract of Ophiocephalus striatus (p <0.05).
Table -2 Clinical And Laboratory Parameters Before And After Administration Of Ophiocephalus Striatus Extract
a normal distribution; mean±SD; paired t-test b abnormal distribution; median (minimum-maximum); Wilcoxon Table 3 showed differences in albumin and adiponectin levels before and after therapy in the chemotherapy and nonchemotherapy groups. No signicant differences were found between chemotherapy and non-chemotherapy groups (p = 0.403 and 0.999).
Table -3 Difference Of Albumin And Adiponectin Level Based On Chemotherapy Category inpaired t-test

DISCUSSION
The scientic development has revealed the fact that Ophiocephalus striatus has an excellent nutritional effect for health. The extract consists of high protein content (especially, albumin and essential amino acids), fats (especially essential fatty acids), minerals (especially Zinc), and some vitamins 9 that are very good for health. Ophiocephalus striatus has been known contain higher protein than other sh species. 10 The albumin levels can reach 6.22%.
This study showed an increase in weight and BMI of cancer cachexia patients although statistically, the increase in BMI and weight was not signicant. Previous studies regarding the use of Ophiocephalus striatus extract on HIV-AIDS and COPD patients with cachexia showed signicant body weight 11, 12 improvement after administration of this extract.
The insignifcant increase of body weight in this study might be due to short duration of study. The better results on weight gain and BMI might be achieved if the time of administration of Ophiocephalus striatus extract were longer.
This study showed an increase in serum albumin levels of c a n c e r c a c h e x i a p a t i e n t s a f t e r a d m i n i s t r a t i o n o f Ophiocephalus striatus extract at a dose of 5000 mg twice a day for two weeks. Previous studies have shown an increase in serum albumin after administration of snakehead sh [11] [12] [13] extract. Ophiocephalus striatus extracts were proven to be a food supplement that can increase serum albumin levels in patients with hypoalbuminemia.
Anti-inammation effect of adiponectin may be mediated by various potential pathways including the capacity to suppress TNF synthesis and the ability to induce the production of anti-inammatory cytokines such as IL-10 and IL-1 receptor antagonists. Adiponectin plays an important role in inhibiting the activation of macrophages. Adiponectin inhibits transactivation of NF-B and induces anti-inammatory IL-10 14 through ERK1/2 and AKT by mediation of AdipoR1. This anti-inammatory effect has been proved in osteoarthritis 15 patients. There was no signicant differences between serum CRP levels before and after administration of Ophiocephalus striatus extract. It might be concluded that extract of Ophiocephalus striatus had anti-inammatory effects through the leptin and adiponectin pathways.
There was no signicant difference in complete blood count, liver and kidney function in the subjects before and after administration of Ophiocephalus striatus extract. No side effect was observed on the subject during the study period. This has been proven that the administration of snakehead sh extract for two weeks did not cause side effects.
The increase of serum albumin levels in the chemotherapy group was higher than in the non-chemotherapy group. Although statistically this difference was not signicant, but based on the results, we can conclude that administration of Ophiocephalus striatus extract could help clinical improvement in cancer patients undergoing chemotherapy. There were some limitations of the study. The short duration in the study led to non-optimal results in both benets and side effects. Longer duration is needed to get more exact results from the effects of Ophiocephalus striatus extract.
CONCLUSIONS
The increases of serum adiponectin and albumin levels in c a n c e r c a c h e x i a p a t i e n t s w e r e o b t a i n e d a f t e r administration of Ophiocephalus striatus extract 5000 mg twice a day for two weeks. 
